Skip To Voice Support Menu
For Body
For Menu
For Local Menu
Site Map
Text Size
Normal
Home
About Chugai
Group Companies
Patients
Research and Development
Careers
Contact
Chugai Pharma USA, LLC is now Chugai Pharma USA, Inc
Aug 11, 2015 Caution Regarding False Solicitations on Behalf of Chugai
May 14, 2015 Warning against Phishing e-mails and social networking sites using the name of Chugai Pharmaceutical
News Releases
What's New
02 Oct
Chugai’s Enspryng Launched in Taiwan as First Indication for Neuromyelitis Optica Spectrum Disorder (NMOSD)
25 Sep
Chugai Obtains Approval for Additional Indication of Actemra for Cytokine Release Syndrome Induced by Cancer Therapy in Japan
25 Sep
Chugai Obtains Regulatory Approval for Phesgo, the Fixed-Dose Subcutaneous Combination of Perjeta and Herceptin for HER2-Positive Breast and Colorectal Cancer
06 Sep
FDA Accepts Application for Chugai’s Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition
More
Videos & Advertisements
Share this site